Skip to content

Novavax NVAX Commitments & Contingencies

Commitments & Contingencies at other companies

Tandem Diabetes Care logo
Tandem Diabetes CareTNDM
$0
Hagerty logo
HagertyHGTY
$0
Global Net Lease logo
Global Net LeaseGNL
$0
Piedmont Office Realty Trust logo
Piedmont Office Realty TrustPDM
$0
OGS
ONE GASOGS
$0
MidCap Financial Investment Corporation logo
MidCap Financial Investment CorporationMFIC
$8.98M+76.0%

Other financials

Income statement

See full
Revenue$139.5M-79.1%
Gross profit$108.8M-83.3%
Operating income-$15.4M-103%
Net income-$9.5M-102%
EPS (diluted)-$0.06-102%

Balance sheet

See full
Cash & equivalents$228.4M-13.3%
Total debt$295.1M+404%
Total equity-$144.8M-91.4%
Total assets$1.0B-19.3%

Cash flow

See full
Operating cash flow-$32.4M+82.5%
CapEx$1.3M-20.4%
Free cash flow-$33.7M+82.0%

Valuation

See full
Market cap$1.46B+41.0%
Enterprise value$1.53B+83.6%
P/S2.5×+1.6×

Profitability

See full
Gross margin85%-2.5pp
Operating margin-13.1%-45.9pp
Net margin-14.7%-52.9pp
FCF margin-58.9%-61.4pp

Returns & leverage

See full
Return on equity-238.6%
Debt / equity1.5×
Current ratio2.5×+0.4×

Where this comes from

Reported directly by Novavax in its filing.

Tagged under the XBRL concept us-gaap:CommitmentsAndContingencies.

The official record: Novavax’s 10-Q, filed November 7, 2018, on SEC EDGAR. View the filing →